Event Title

Malaria Control in Africa: The Story So Far

Streaming Media

Description

Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. It is preventable and curable. In 2017, there were an estimated 219 million cases of malaria in 87 countries. The estimated number of malaria deaths stood at 435,000 in 2017. In 2017, nearly half of the world's population was at risk of malaria. Most malaria cases and deaths occur in sub-Saharan Africa. However, the WHO regions of South-East Asia, Eastern Mediterranean, Western Pacific, and the Americas are also at risk. The WHO African Region carries a disproportionately high share of the global malaria burden. In 2017, the region was home to 92% of malaria cases and 93% of malaria deaths. Children under 5 years of age are the most vulnerable group affected by malaria; in 2017, they accounted for 61% (266,000) of all malaria deaths worldwide. The WHO Global Technical Strategy for Malaria 2016-2030 – adopted by the World Health Assembly in May 2015 – provides a technical framework for all malaria-endemic countries. It is intended to guide and support regional and country programs as they work towards malaria control and elimination. We will discuss the history of elimination of malaria from some parts of the developed world, the measures the developing world is taking towards the elimination of malaria and the possibility that malaria could come back to the USA.

About the Lecturer: Tsiri Agbenyega obtained a Bachelor of Medicine, Bachelor of Surgery (MB. ChB) from the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana, in 1982. After earning qualification as a doctor, he did rotations in the departments of Medicine, Surgery, Obstetrics & Gynecology, and Pediatrics at the Komfo Anokye Teaching Hospital in Kumasi. He obtained a PhD in Physiology from the University of Manchester (UK) in 1991. He started teaching Physiology in the School of Medical Sciences KNUST in 1991.

He is a former Dean of the Medical School and a former Provost of the College of Health Science, Kwame Nkrumah University of Science and Technology. He is currently a Professor in the Department of Physiology in the School of Medical Sciences. He is the Principal Investigator at the Malaria Vaccine Trial Centre at the Agogo Presbyterian Hospital and the Medical Director at the HopeXchange Medical Centre in Kumasi.

Document Type

Event

Start Date

16-10-2019 11:30 AM

End Date

16-10-2019 12:50 PM

Location

Fairhaven College Auditorium

Resource Type

Moving image

Duration

1:09:11

Title of Series

World Issues Forum

Genre/Form

lectures

Contributing Repository

Fairhaven College of Interdisciplinary Studies

Program

World Issues Forum

Type

Moving Image

Keywords

Malaria control

Rights

This resource is displayed for educational purposes only and may be subject to U.S. and international copyright laws.

Language

English

Format

video/mp4

Share

COinS
 
Oct 16th, 11:30 AM Oct 16th, 12:50 PM

Malaria Control in Africa: The Story So Far

Fairhaven College Auditorium

Malaria is a life-threatening disease caused by parasites that are transmitted to people through the bites of infected female Anopheles mosquitoes. It is preventable and curable. In 2017, there were an estimated 219 million cases of malaria in 87 countries. The estimated number of malaria deaths stood at 435,000 in 2017. In 2017, nearly half of the world's population was at risk of malaria. Most malaria cases and deaths occur in sub-Saharan Africa. However, the WHO regions of South-East Asia, Eastern Mediterranean, Western Pacific, and the Americas are also at risk. The WHO African Region carries a disproportionately high share of the global malaria burden. In 2017, the region was home to 92% of malaria cases and 93% of malaria deaths. Children under 5 years of age are the most vulnerable group affected by malaria; in 2017, they accounted for 61% (266,000) of all malaria deaths worldwide. The WHO Global Technical Strategy for Malaria 2016-2030 – adopted by the World Health Assembly in May 2015 – provides a technical framework for all malaria-endemic countries. It is intended to guide and support regional and country programs as they work towards malaria control and elimination. We will discuss the history of elimination of malaria from some parts of the developed world, the measures the developing world is taking towards the elimination of malaria and the possibility that malaria could come back to the USA.

About the Lecturer: Tsiri Agbenyega obtained a Bachelor of Medicine, Bachelor of Surgery (MB. ChB) from the Kwame Nkrumah University of Science and Technology (KNUST), Kumasi, Ghana, in 1982. After earning qualification as a doctor, he did rotations in the departments of Medicine, Surgery, Obstetrics & Gynecology, and Pediatrics at the Komfo Anokye Teaching Hospital in Kumasi. He obtained a PhD in Physiology from the University of Manchester (UK) in 1991. He started teaching Physiology in the School of Medical Sciences KNUST in 1991.

He is a former Dean of the Medical School and a former Provost of the College of Health Science, Kwame Nkrumah University of Science and Technology. He is currently a Professor in the Department of Physiology in the School of Medical Sciences. He is the Principal Investigator at the Malaria Vaccine Trial Centre at the Agogo Presbyterian Hospital and the Medical Director at the HopeXchange Medical Centre in Kumasi.